40
Participants
Start Date
August 12, 2022
Primary Completion Date
August 31, 2027
Study Completion Date
August 31, 2028
Demographics, diagnosis type, genotype, lipid profile, renal function profile, treatment allocation, ophthalmology exam, country of residence.
The study will collect extensive historical health data (retrospective), and at baseline will conduct an extensive characterization of the disease progression using the parameters described above.
RECRUITING
University of Pennsylvania, Philadelphia
University of Pennsylvania
OTHER